AK1320 MS / Asahi Kasei  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AK1320 MS / Asahi Kasei
NCT04483297: First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

Terminated
1
30
Canada
AK1320 MS, Control
Asahi Kasei Pharma Corporation, Emergent Clinical Consulting, LLC
Degenerative Spondylolisthesis, Spinal Stenosis
11/23
01/24

Download Options